Nancy Olivieri
Nancy Fern Olivieri (born 1954) is a prominent Toronto haematologist and researcher with an interest in the treatment of haemoglobinopathies. She is best known for a protracted struggle with the Hospital for Sick Children and the pharmaceutical company Apotex about the drug deferiprone. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Nancy Olivieri', query time: 0.04s
Refine Results
-
1
-
2
-
3
Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia by Paul Harmatz, Maureen M. Jonas, Janet L. Kwiatkowski, Elizabeth C. Wright, Roland Fischer, Elliott Vichinsky, Patricia J. Giardina, Ellis J. Neufeld, John Porter, Nancy Olivieri
Published 2008-08-01
Article -
4
Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial by Patrick B. Walter, Eric A. Macklin, John Porter, Patricia Evans, Janet L. Kwiatkowski, Ellis J. Neufeld, Thomas Coates, Patricia J. Giardina, Elliott Vichinsky, Nancy Olivieri, Daniele Alberti, Jaymes Holland, Paul Harmatz
Published 2008-06-01
Article -
5
A “One-Stop” Screening Protocol for Haemoglobinopathy Traits and Iron Deficiency in Sri Lanka by Angela Allen, Angela Allen, Shiromi Perera, Luxman Perera, Rexan Rodrigo, Sachith Mettananda, Agnes Matope, Ishari Silva, Nizri Hameed, Christopher A. Fisher, Nancy Olivieri, David J. Weatherall, Stephen Allen, Anuja Premawardhena, Anuja Premawardhena
Published 2019-08-01
Article -
6
Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians by Charles L. Bennett, Nancy Olivieri, Shamia Hoque, David Aboulafia, Anne Ventrone, Courtney Lubaczewski, Betty Dong, Benjamin Schooley, Bartlett J. Witherspoon, Paul S. Ray, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Dennis Mangano, Christina Mora-Mangano, June M. McKoy, Martin Schoen, Kevin Knopf, Linda Martin, Steven Rosen
Published 2022-06-01
Article -
7
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adv... by Charles L. Bennett, Shamia Hoque, Nancy Olivieri, Matthew A. Taylor, David Aboulafia, Courtney Lubaczewski, Andrew C. Bennett, Jay Vemula, Benjamin Schooley, Bartlett J. Witherspoon, Ashley C Godwin, Paul S. Ray, Paul R. Yarnold, Henry C. Ausdenmoore, Marc Fishman, Georgne Herring, Anne Ventrone, Juan Aldaco, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Paul R. Yarnold, Robert Marx, Cesar Migliorati, Salvatore Ruggiero, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Y. Tony Yang, Martin W. Schoen, Kevin Knopf, Linda Martin, Oliver Sartor, Steven Rosen, William K. Smith
Published 2021-01-01
Article